Literature DB >> 2390670

Phenthonium, a quaternary derivative of (-)-hyoscyamine, enhances the spontaneous release of acetylcholine at rat motor nerve terminals.

M L Fann1, C Souccar, A J Lapa.   

Abstract

1. A quaternary derivative of (-)-hyoscyamine, phenthonium (Phen) induced a concentration-dependent increase in the rate of spontaneous quantal release of acetylcholine (ACh) at the mammalian neuromuscular junction, as shown by intracellular recordings of the miniature endplate potentials (m.e.p.ps) in rat diaphragm muscles. 2. The prejunctional effect of Phen (10-50 microM) was reversible, unrelated to temperature (22 degrees-35 degrees C), unaltered by either changes in [Ca2+]o or by high [Mg2+]o, and was not induced by membrane depolarization. 3. Simultaneously, Phen reduced the amplitude of m.e.p.ps by a postjunctional action. 4. The muscarinic agonist oxotremorine did not prevent the increase in m.e.p.p. frequency induced by Phen. Cholinesterase inhibition with neostigmine potentiated the prejunctional effect induced by a low (20 microM) but not a high (50 microM) concentration of Phen. 5. The increase in m.e.p.p. frequency induced by Phen was not influenced by previous incubation with either atropine (0.01-10 microM) or (+)-tubocurarine (0.05-0.1 microM). Each antagonist however, intensified the postjunctional effect of Phen. 6. Phen (20 microM) did not influence the quantal contents of e.p.ps in cut-muscle preparations or in the presence of high [Mg2+]o. A high concentration of Phen (50 microM) increased the rundown of e.p.p. trains evoked at 10-50 Hz. 7. The results indicate that the facilitatory prejunctional action of Phen cannot be explained by an antimuscarinic activity. A possible interaction of the antagonist with putative prejunctional nicotinic cholinoceptors however, was not excluded.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2390670      PMCID: PMC1917815          DOI: 10.1111/j.1476-5381.1990.tb15825.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  29 in total

1.  The stochastic properties of spontaneous quantal release of transmitter at the frog neuromuscular junction.

Authors:  I Cohen; H Kita; W Van Der Kloot
Journal:  J Physiol       Date:  1974-01       Impact factor: 5.182

Review 2.  The regulation of intracellular calcium in presynaptic nerve terminals.

Authors:  M P Blaustein; R W Ratzlaff; N K Kendrick
Journal:  Ann N Y Acad Sci       Date:  1978-04-28       Impact factor: 5.691

3.  Does curare affect transmitter release?

Authors:  A Auerbach; W Betz
Journal:  J Physiol       Date:  1971-03       Impact factor: 5.182

4.  Transversaly cut diaphragm preparation from rat. An adjuvant tool in the study of the physiology and pbarmacology of the myoneural junction.

Authors:  J A Barstad; G Lilleheil
Journal:  Arch Int Pharmacodyn Ther       Date:  1968-10

5.  Feedback control of transmitter release at the neuromuscular junction.

Authors:  W C Bowman; I G Marshall; A J Gibb; A J Harborne
Journal:  Trends Pharmacol Sci       Date:  1988-01       Impact factor: 14.819

6.  Mechanism of acetylcholine release: possible involvement of presynaptic muscarinic receptors in regulation of acetylcholine release and protein phosphorylation.

Authors:  D M Michaelson; S Avissar; Y Kloog; M Sokolovsky
Journal:  Proc Natl Acad Sci U S A       Date:  1979-12       Impact factor: 11.205

7.  The action of tubocurarine and atropine on the normal and denervated rat diaphragm.

Authors:  R Beránek; F Vyskocil
Journal:  J Physiol       Date:  1967-01       Impact factor: 5.182

8.  Absence of [125I] alpha-bungarotoxin binding to motor nerve terminals of frog, lizard and mouse muscle.

Authors:  S W Jones; M M Salpeter
Journal:  J Neurosci       Date:  1983-02       Impact factor: 6.167

9.  Spontaneous and evoked activity of motor nerve endings in calcium Ringer.

Authors:  B Katz; R Miledi
Journal:  J Physiol       Date:  1969-08       Impact factor: 5.182

10.  The effects of atropine and oxotremorine on acetylcholine release in rat phrenic nerve-diaphragm preparations.

Authors:  E T Abbs; D N Joseph
Journal:  Br J Pharmacol       Date:  1981-06       Impact factor: 8.739

View more
  4 in total

1.  Studies on the cardiac actions of flosequinan in vitro.

Authors:  R W Gristwood; J Beleta; J Bou; I Cardelús; A G Fernández; J Llenas; P Berga
Journal:  Br J Pharmacol       Date:  1992-04       Impact factor: 8.739

2.  Differential inotropic effects of flosequinan in ventricular muscle from normal ferrets versus patients with end-stage heart failure.

Authors:  C L Perreault; N L Hague; E Loh; I M Hunneyball; M F Sim; J P Morgan
Journal:  Br J Pharmacol       Date:  1992-07       Impact factor: 8.739

3.  Blockade of acetylcholine release at the motor endplate by a polypeptide from the venom of Phoneutria nigriventer.

Authors:  C Souccar; M do C Gonçalo; A J Lapa; L R Troncone; I Lebrun; F Magnoli
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

4.  Natural compounds endowed with cholinergic or anticholinergic activity. Enhancement of acetylcholine release by a quaternary derivative of L-hyoscyamine.

Authors:  Caden Souccar; Ana Lucia V Salamanca; Mirtes M Tanae; Maria Teresa R Lima-Landman; Antonio José Lapa
Journal:  J Mol Neurosci       Date:  2009-08-18       Impact factor: 3.444

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.